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Abstract
Sex determination in mammals is controlled by the presence or absence of the Y-linked gene SRY. In the developing male
(XY) gonad, sex-determining region of the Y (SRY) protein acts to up-regulate expression of the related gene, SOX9, a
transcriptional regulator that in turn initiates a downstream pathway of testis development, whilst also suppressing ovary
development. Despite the requirement for a number of transcription factors and secreted signalling molecules in sex
determination, intracellular signalling components functioning in this process have not been defined. Here we report a role
for the phylogenetically ancient mitogen-activated protein kinase (MAPK) signalling pathway in mouse sex determination.
Using a forward genetic screen, we identified the recessive boygirl (byg) mutation. On the C57BL/6J background, embryos
homozygous for byg exhibit consistent XY gonadal sex reversal. The byg mutation is an A to T transversion causing a
premature stop codon in the gene encoding MAP3K4 (also known as MEKK4), a mitogen-activated protein kinase kinase
kinase. Analysis of XY byg/byg gonads at 11.5 d post coitum reveals a growth deficit and a failure to support mesonephric
cell migration, both early cellular processes normally associated with testis development. Expression analysis of mutant XY
gonads at the same stage also reveals a dramatic reduction in Sox9 and, crucially, Sry at the transcript and protein levels.
Moreover, we describe experiments showing the presence of activated MKK4, a direct target of MAP3K4, and activated p38
in the coelomic region of the XY gonad at 11.5 d post coitum, establishing a link between MAPK signalling in proliferating
gonadal somatic cells and regulation of Sry expression. Finally, we provide evidence that haploinsufficiency for Map3k4
accounts for T-associated sex reversal (Tas). These data demonstrate that MAP3K4-dependent signalling events are required
for normal expression of Sry during testis development, and create a novel entry point into the molecular and cellular
mechanisms underlying sex determination in mice and disorders of sexual development in humans.
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Introduction
Sex determination is the process by which an embryo develops
into a male or female, namely, the formation of testes in an XY
embryo and ovaries in an XX embryo. In the mouse, this process
begins with commitment of cells of the bipotential genital ridge to
either the testicular or ovarian fate at 11.5 d post coitum (dpc) [1].
In mammals such as mice and humans, this commitment depends
on the presence or absence of the Y-linked testis-determining gene,
SRY [2–4].
During the search for the elusive mammalian testis-determining
factor, it was a criterion of correct identification that any candidate
gene be associated with mutations that cause pure (gonadal) XY
sex reversal: the development of an ovary in an XY individual.
Such mutations in SRY were readily discovered in mice [5] and
humans [6] exhibiting sex reversal, and this link with sex reversal
has been a constant theme in the subsequent identification of
novel, mostly autosomal, genes functioning in sex determination.
Instances of XY sex reversal in the mouse associated with single
gene mutations remain relatively uncommon. Excluding Sry, they
include targeted mutations of Sox9 [7,8], Dax1 [9], Fgf9 [10], Fgfr2
[11,12], Gata4/Fog2 [13,14], Cbx2 (M33) [15], and Wt1(+KTS)
[16]. Mice harbouring targeted mutations in three members of the
insulin-receptor signalling pathway also exhibit XY sex reversal
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[17]. In several of these cases, variability exists in the degree of sex
reversal observed, depending on genomic context. The C57BL/6J
background often biases gonadal development in favour of ovarian
tissue in mutant XY embryos and this ‘‘B6 sensitivity’’ increases
still further if the AKR/J Y chromosome (YAKR) is present [14].
Additional genes have been identified that disrupt testis develop-
ment, affecting testis cord formation or the differentiation of testis-
specific cell lineages. These include Dhh [18–20], Pdgfra [21], Pod1
[22], Arx [23], Wnt4 [24], and Spry2 [25]. The contribution of
other protestis genes to sex determination, such as Sf1 [26], Dmrt1
[27], and Sox8 [7], can be difficult to discern owing to functions of
such genes earlier in gonad development or functional redun-
dancy.
In addition to the contribution of specific genes, other
autosomal loci have been reported to control sex determination
in the mouse. Such loci have been identified on the basis of genetic
segregation in cases of sex reversal observed when the Y
chromosome of the C57BL/6 strain is replaced by that of Mus
domesticus poschiavinus [28], or on the basis of their modifying the
phenotypic effect of another sex determining locus [29,30].
The search for novel sex determining genes has been driven in
recent years by the transcriptional properties of candidate genes
identified by expression profiling [31–35]. However, such gene-
driven approaches have not yielded a significant number of novel
sex reversal phenotypes or abnormalities of gonadal differentiation
that could act as important models for the investigation of the
molecular genetic basis of sex determination. Notable exceptions
to this general observation include the genes Cyp26b1 [36,37] and
Pgds [38,39], whose roles in germ cell and somatic cell
development, respectively, were established partly on the basis of
earlier observations on their male-specific expression derived from
systematic expression screens.
As an alternative to expression-based screens, we have
employed a forward genetic approach to identifying loci
controlling sexual development in the mouse. Using N-ethyl-N-
nitrosourea (ENU) mutagenesis and a three-generation (G3)
breeding scheme, we screened for abnormalities of the developing
gonads in embryos homozygous for induced mutations. In one
mutant pedigree, RECB/31, we identified XY embryos exhibiting
abnormal testis cord development and, in some cases, gonadal sex
reversal. We have named this mutant line boygirl (byg). Genetic
mapping placed byg on the proximal region of mouse Chromo-
some 17 and molecular studies revealed that the byg phenotype is
caused by a point mutation in the Map3k4 (Mekk4) gene. Embryos
doubly heterozygous for both the Map3k4byg allele and a targeted
null allele of Map3k4 (Map3k4tm1Flv) exhibited neural tube defects
and XY gonadal sex reversal, confirming that Map3k4 is the causal
gene. Map3k4 encodes a mitogen-activated protein kinase (MAPK)
kinase kinase, demonstrating for the first time a role for MAPK
signalling in mammalian sex determination. We describe molec-
ular and cellular studies on the byg mutant that demonstrate a
requirement for mitogen-activated protein kinase kinase kinase 4
(MAP3K4) in regulating XY gonadal growth, mesonephric cell
migration, and the expression of Sry, and hence Sox9, during XY
gonad development. We also describe genetic experiments that
suggest that loss of Map3k4 is responsible for a previously reported
autosomal sex reversal phenomenon, T-associated sex reversal
(Tas) [40,41].
Results
Identification and Molecular Characterisation of byg
Mutant
Line 31 (RECB/31) was identified in a forward genetic
(phenotype-driven) screen for embryonic gonad abnormalities
after ENU mutagenesis (see Materials and Methods for details).
Embryos homozygous for ENU-derived mutations were isolated
and examined for a variety of morphological abnormalities. One
RECB/31 embryo, dissected at 13.5 dpc, exhibited spina bifida,
mild oedema, and also contained gonads shaped like normal testes
but with no visible testis cords (Figure 1A and 1B). A second,
independent RECB/31 litter contained an embryo with spina
bifida and testes that had fewer cords than normal with an
irregular morphology (Figure 1C). Having identified these
individuals, subsequent RECB/31 embryos were examined and
gonads were collected for sexing and wholemount in situ
hybridisation (WMISH). In this manner, another XY individual
was identified in which the gonads were morphologically ovarian
at the same stage (Figure 1D). WMISH analysis of gonads from
these three abnormal embryos using the Sertoli cell marker Sox9
confirmed the disruption to testis development and its variable
severity as described above (Figure 1B–1D). In each case, Sox9
expression was still prominent. However, in the case of the XY
gonad with an ovarian appearance, expression was restricted to
the central portions of the gonad and absent from the poles. This
observed phenotypic variability, and that of subsequent mutants
identified in the RECB/31 pedigree, is likely due to the mixed
genetic background of the embryos examined. All embryos with
abnormal XY gonads exhibited failure of neural tube closure,
either spina bifida or exencephaly (unpublished data). Embryonic
death of homozygous mutants was commonly observed after
15.5 dpc. Because of the observed gonadal abnormalities and
apparent XY gonadal sex reversal, this mutant line was named
boygirl (byg).
During subsequent generations of backcrossing onto C3H/HeH
the gonadal phenotype was still robust, although the majority of
RECB/31 XY gonads had the appearance of ovotestes, in which
the central portion of the gonad shows evidence of cord formation,
but the poles are ovarian in both appearance and marker
expression (Figure 1E–1N). No overt abnormalities were observed
in XX byg/byg gonads in these marker studies.
Author Summary
In mammals, whether an individual develops as a male or
female depends on its sex chromosome constitution:
those with a Y chromosome become males because of the
development of the embryonic gonad into a testis. The Y-
linked sex determining gene SRY regulates this process by
initiating a pathway of gene and protein expression,
including the expression of critical autosomal genes such
as SOX9. We identified a mouse mutant that causes
embryonic gonadal sex reversal: the development of
ovaries in an XY embryo. This mutant, which we called
boygirl (byg), was shown to contain an early stop codon
that disrupts the autosomal gene encoding MAP3K4, a
component of the mitogen-activated protein kinase
(MAPK) signaling pathway. Analysis of embryonic XY
gonads suggests that sex reversal is caused by delayed
and reduced expression of the sex-determining gene SRY.
Our data indicate, for the first time, a requirement for
MAPK signaling in the developing XY gonad in order to
facilitate normal expression of SRY and the downstream
testis-determining genes and also suggest that reduced
dosage of MAP3K4 may be the cause of a previously
described autosomal sex-reversing mutation in the mouse.
We predict that loss of MAP3K4 or other MAPK compo-
nents may underlie disorders of sexual development (DSD)
in humans as well.
MAP3K4 Is Required for Mouse Sex Determination
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Identification of additional affected XY gonads permitted
mapping of the byg mutation. Abnormal embryos (n=9) were
typed with a genome-wide panel of 55 SNP markers in order to
identify chromosomal regions that were consistently homozygous
for the C57BL/6-derived allele. Only one region, on proximal
mouse Chromosome 17, showed this feature of genetic association
with byg. This initial linkage was refined by subsequent
backcrossing of byg carrier males with C3H/HeH females and
intercrossing of carrier progeny, identified by SNP haplotype
analysis. Additional SNPs were then used to identify a critical
region, in which the byg mutation must reside, between 9.66 Mb
(rs3665053) and 15.32 Mb (rs13482889) on Chromosome 17. We
used an informatics-based approach to identify candidate genes in
the byg critical region. One such candidate was the gene Map3k4
(also known as Mekk4, GenBank [http://www.ncbi.nlm.nih.gov/
Genbank] number NM_011948), which encodes a MAPK kinase
kinase [42,43]. Mice lacking this gene, which were generated
previously by gene targeting, are associated with perinatal lethality
on the C57BL/6 background [44]. Because homozygous Map3k4
mutant embryos also exhibit neural tube defects and because
Map3k4 is expressed in most embryonic tissues between 9.5 and
15.5 dpc [42,44,45], including the gonads (Figure 2A and 2B), we
examined the sequence of Map3k4 in affected byg/byg embryos. A
single nucleotide substitution at nucleotide position 1,144 of the
Map3k4 open reading frame was identified in the homozygous
form in two independent byg/byg mutants (Figure 2C and 2D).
This substitution replaces an arginine with a premature stop codon
at amino acid position 382 of the 1,597 amino acid MAP3K4
protein. The predicted truncated protein lacks the critical kinase
domain of MAP3K4 and, therefore, lacks any MAPKKK function
(Figure 2E). Absence of full-length (180 kDa) MAP3K4 protein in
byg homozygous mutants was confirmed by Western blotting with
an anti-MAP3K4 antibody (Figure 2F). A kinase-inactive allele of
Map3k4 has previously been shown to have very similar
phenotypic consequences to the null allele [45]. Thus, because
of the effect of the premature stop codon causing loss of the kinase
domain, we conclude that the Map3k4byg allele is a null allele. The
entire colony of byg mice was typed for the presence of the
mutation in Map3k4 and all known byg carriers were heterozygous
for the mutation. The mutation was not found in any wild-type
C57BL/6J or C3H/HeH mice. We concluded, therefore, that the
gonadal phenotype in mutant byg embryos is caused by loss of
MAP3K4 function.
To confirm this, and discount the possibility that a second,
closely linked mutation in an unrelated gene was responsible for
the gonadal phenotype, we studied a second Map3k4 mutant allele
Figure 1. Identification of the bygmutant. (A) Line RECB/31 (boygirl, byg) mutant embryo dissected during the screen at 13.5 dpc. The embryo
shown here has exencephaly, spina bifida, and mild oedema. On the mixed genetic background used for the forward genetic screen, the boygirl XY
gonadal phenotypes observed at 13.5/14.5 dpc ranged from testis-shaped gonads that lacked cords (B), to testes with abnormal cord morphology
and ‘‘missing’’ cords (arrowhead, C) through to XY gonads with an overt ovarian morphology (right, D). All gonads shown here were hybridised with a
Sox9 probe to assess cord structure and differentiation of Sertoli cells. Note the higher than normal (with respect to ovary development) levels of Sox9
transcript in the boygirl XY ‘‘ovary’’ in (D) and the absence of Sox9 from the poles of this gonad (arrowheads, D), a characteristic of ovotestis
development. Wild-type littermate gonads from unaffected XY and XX embryos are shown for comparison. (E–G) After further out-crossing of the byg
mutation to C3H/HeH for mapping purposes, XY byg/byg gonads exhibited further signs of ovotestis formation. For example, expression of the germ
cell marker Oct4 at 13.5 dpc revealed a cord-like pattern only in the centre of the gonad shown here (bracket, E), made clearer by sectioning (bracket,
F). Note also the thickened capsule over the central testicular area. Control gonads exhibited robust cord formation throughout their length (G). (H)
XX byg/byg gonads exhibited a normal pattern of Oct4 expression. (I) The poles of XY byg/byg gonads were also characterised by loss of male-specific
genes, such as the Leydig cell marker 3b-HSD (bracket). (J) Abnormal expression of female-specific marker Wnt4 at the gonadal poles (arrowheads
next to gonad on left) at 14.5 dpc. (K) Normal expression ofWnt4 in XX byg/byg gonad. (L) Absence of expression of meiotic marker Stra8 in wild-type
XY gonad. (M) Prominent Stra8 expression in XX byg/byg gonad. (N) Expression of Stra8 at gonadal poles in XY byg/byg gonad (brackets).
doi:10.1371/journal.pbio.1000196.g001
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Figure 2. The byg phenotype is caused by a point mutation in Map3k4. (A) WMISH of 12.5 dpc XY gonads with a Map3k4 probe revealing
widespread expression, including in newly formed testis cords. (B) Longitudinal section through male gonad at 13.5 dpc, after WMISH, showing
Map3k4 expression in testis cords. (C, D) Sequence traces from heterozygous (byg/+, C) and homozygous (byg/byg, D) individuals reveal an A to T
transversion at nucleotide position 1,144 of the Map3k4 open reading frame of the byg allele. (E) This mutation replaces an arginine with a premature
stop codon (asterisk) at amino acid position 382 of the 1,597 amino acid MAP3K4 protein. The predicted truncated protein lacks the critical kinase
domain (S_TKc) and, therefore, any MAPKKK function. (F) Western blotting of protein extracted from byg/byg and +/+ embryos shows absence of full-
length (180 kDa) MAP3K4 in mutant homozygotes. The position of size markers is shown on the left. The upper band found in both lanes is due to
cross-reaction of the antibody with an unrelated protein. (G) A genetic complementation test was performed to confirm that homozygosity for the
Map3k4 point mutation caused the byg gonadal phenotype. XY mutant embryos heterozygous for both the Map3k4byg and targeted Map3k4tm1Flv
alleles were dissected at 14.5 dpc and contained gonads with an overt ovarian morphology (central gonad). XX and XY littermate controls are also
shown. (H) Hybridisation of a Sox9 probe to a doubly heterozygous XY gonad (left) reveals little expression of the Sertoli cell marker, in contrast to an
XY control (right). (I) XY gonad from 14.5 dpc embryo homozygous for the Map3k4tm1Flv allele (2/2) exhibits overt ovarian morphology and an
absence of Sox9 (right), in contrast to XY littermate control (left). (J) XY gonad from homozygous knockout embryo (2/2) also expresses high levels
of Wnt4 (central gonad). XY and XX control gonads are shown on left and right, respectively.
doi:10.1371/journal.pbio.1000196.g002
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(Map3k4tm1Flv) generated by gene targeting [44]. Embryos
homozygous for the Map3k4tm1Flv allele exhibit neural tube defects
and die perinatally, although there have been no descriptions of
sexual development in these individuals. Embryos doubly
heterozygous for both Map3k4byg and Map3k4tm1Flv were examined
at 14.5 dpc and exhibited neural tube defects (unpublished data).
All XY embryos contained gonads with an overt ovarian
appearance (Figure 2G), and these failed to express Sox9 at
significant levels (Figure 2H). The absence of any overt testicular
tissue in these XY embryonic gonads is likely due to the increased
contribution from the C57BL/6J genome in these individuals.
Embryos homozygous for the targeted allele, which was
maintained on the C57BL/6J background, also exhibited gonadal
sex reversal, with affected XY embryos containing gonads with
ovarian morphology, lacking Sox9 and expressing Wnt4, a marker
of ovarian differentiation (Figure 2I and 2J). Thus, these data
confirm that Map3k4 is the gene disrupted in the byg mutant and
that MAP3K4 is required for testis determination in mice.
Phenotypic Characterisation of the byg Mutant
Evidence exists that the C57BL/6J background is sensitised to
disruptions to XY gonad development, and this conclusion
appeared to be supported by the increased severity of the XY
gonadal phenotype observed in embryos heterozygous for both
Map3k4byg and Map3k4tm1Flv, and homozygous for Map3k4tm1Flv, in
which the contribution from C57BL6/J was greater. Thus, we
performed a detailed examination of embryos homozygous for
Map3k4byg after backcrossing to C57BL6/J for at least two
generations. We examined cell proliferation, mesonephric cell
migration, and cellular differentiation in mutant and wild-type
gonads because all these processes are required for normal testis
development [1,46,47].
Cellular proliferation is an important component of the
organogenetic programme of testis development [48,49]. Gonadal
cell proliferation was examined at 11.5 dpc (17–18 tail somites
[ts]), 12.0 dpc (20–22 ts), and 12.25 (24 ts) in the coelomic region
of gonads from byg/byg and control littermates using immuno-
staining with an antibody for the mitotic marker phosphorylated
histone H3 (pHH3). Somatic cell proliferation in XY byg/byg
gonads appeared reduced in the coelomic region in comparison to
wild-type XY embryonic gonads at all stages examined (Figure 3;
Table 1). Moreover, at the 22- and 24 ts stages (12.0–12.25 dpc),
the coelomic region of control XY gonads was thickened and
contained a larger number of somatic cells, in contrast to byg/byg
XY gonads, which had fewer cells in this region and resembled
wild-type XX gonads of the same stage (Figure 3). We conclude
that cellular proliferation, and thus gonadal growth, in the
coelomic region is severely compromised in byg/byg XY gonads
at an early stage.
Increased levels of apoptosis have previously been described in
the neural tube of mice lacking Map3k4 [44]. For this reason we
examined levels of apoptosis in the byg/byg XY gonad and controls
at 17 ts using an antibody to cleaved caspase 3. We observed very
few positive cells in mutant and control gonads, although large
numbers of apoptotic cells were observed in a positive control
(interdigital mesenchyme of the developing limb) using this assay
(unpublished data). Thus, we cannot attribute impaired gonadal
growth in XY byg/byg embryos to increased levels of apoptosis.
Testis cord formation in the mouse requires cell migration from
the associated mesonephros into the XY gonad in a male-specific
fashion [50–53]. To examine mesonephric cell migration into the
XY byg/byg gonad we first examined development of mutant
gonads when explanted from the embryo at 11.5 dpc and cultured
in vitro. Control gonads (wild-type and byg/+ littermates) formed
clear testis cords after 2 d of culture and expressed the Sertoli cell
marker, Sox9 (n=3) (Figure S1A). In contrast, we did not observe
any testis cords in cultured XY gonads from byg/byg embryos
(n=3) (Figure S1B and S1D). WMISH analysis revealed that these
cord-free XY gonads failed to express Sox9 (Figure S1B), indicating
a failure to execute the program of testis differentiation. In
contrast, high levels of Wnt4 expression in the mutant XY gonads
indicated an activation of the ovarian pathway (Figure S1D).
To examine whether the severe disruption to cord formation in
the byg/byg gonad was associated with any loss of mesonephric cell
migration, we performed recombination experiments in which
mesonephroi ubiquitously expressing green fluorescent protein
(GFP) were cultured adjacent to a byg/byg XY gonad from
11.5 dpc. Cell migration into control XY gonads was prominent
after 48 h of culture (Figure S1E). In contrast, little or no cell
migration was detected in cultured byg/byg gonads (Figure S1F).
These data suggest that two early cellular processes associated
specifically with XY gonad development, cell proliferation in the
coelomic growth zone and mesonephric cell migration, are
disrupted in the absence of MAP3K4.
In order to address the molecular basis of these defects, we next
investigated the expression of key male- and female-determining
genes and gene-products between 11.5 and 14.5 dpc, stages of
gonad development between which the male and female fates are
established and the programme of sexually dimorphic morpho-
genesis is executed. Several molecules have been shown to be
required for normal testis determination, including SRY [5],
fibroblast growth factor 9 (FGF9) [10], FGFR2 [11,12], and SRY-
like HMG box 9 (SOX9) [7,8]. Current understanding suggests
that SRY, in concert with SF1, acts to up-regulate Sox9 expression
in the XY gonad at 11.5 dpc [54,55]. Sox9 expression is then
maintained at a high level by a positive feedback loop with FGF9/
FGFR2, and acts to antagonise function of the ovary-determining
gene Wnt4 [56]. A role for prostaglandin D2 in the regulation of
Sox9 expression has also been proposed [12,39,57,58]. Down-
stream of SOX9, genes such as Amh [59] and Vanin-1 [31,32,60],
with male-determining effects, are transcriptionally activated, and
germ cell fate is established by modulation of retinoic acid
signalling [36,37]. These molecular events are associated with
precise spatial (cellular and subcellular) and temporal expression
profiles of genes and their protein products, often in a sexually
dimorphic manner.
Given its central role in testis development we began our study
with an analysis of Sox9 expression. From 11.5 dpc onwards Sox9
transcription in control XY gonads is prominent, initially in pre-
Sertoli cells and subsequently in Sertoli cells of the seminiferous
cords/tubules. However, analysis of byg/byg homozygotes revealed
dramatically reduced levels of Sox9 transcript (Figure 4). At
14.5 dpc the byg/byg XY gonad resembles an ovary morpholog-
ically and no significant Sox9 transcription was detectable
(Figure 4A). This loss of a Sertoli cell marker in mutant XY
gonads was accompanied by elevated expression of two known
female-specific markers at the same stage, Stra8 and Wnt4
(Figure 4B and 4C). Expression of these genes indicates that the
ovarian pathway of development, including entry of germ cells
into meiosis, is activated in vivo in the absence of MAP3K4.
At 11.5 dpc, the sex-determining stage of gonadogenesis, little
or no Sox9 transcript was observed (Figure 4E), and this loss of
expression was confirmed by immunostaining of mutant and
control gonads at the same stage with an anti-SOX9 antibody
(Figure 4G–4I). However, Wnt4 expression was prominent in the
XY byg/byg gonad at 11.5 dpc, in contrast to wild-type controls
(Figure 4F). Interestingly, Sox9 transcription at 11.5 dpc in mutant
gonads on the C3H/HeH background was reduced in comparison
MAP3K4 Is Required for Mouse Sex Determination
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Figure 3. Reduced gonadal growth in XY byg/byg embryos between 11.5 and 12.25 dpc. (A) Somatic cell proliferation in the coelomic
region of control and XY byg/byg gonads was analysed by confocal imaging of wholemount organs after immunostaining with anti-PECAM (green)
and anti-phospho-histone H3 (red) antibodies. Cell nuclei were visualised using DAPI staining (blue). All gonads were staged accurately by counting ts
(ts number shown on left). The coelomic growth zone characteristic of XY gonads is shown with white brackets in the 22 ts and 24 ts samples. This
thickened zone of proliferating somatic cells is not found in XY byg/byg or XX +/+ gonads at any of the stages analysed. (B) Counts in the coelomic
region of total number of somatic cells and mitotic (pHH3-positive) cells in XX/XY wild-type (wt) and XY byg/byg (mut) gonads at the stages shown in
(A). Cell counts were performed on limited numbers of XX byg/byg gonads at 18 ts and 20–22 ts. Numbers were comparable with wild-type XX and XY
byg/byg samples (unpublished data). For details of cell counting methodology and statistical tests see Materials and Methods and Table 1.
doi:10.1371/journal.pbio.1000196.g003
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to controls (Figure 4D), but not to the same degree as the C57BL/
6J-derived mutant gonads at the same stage. Loss of Sox9
expression is associated with XY sex reversal in a number of
genetic contexts, and mice homozygous for a loss-of-function allele
of Sox9 targeted to the developing XY gonads by Cre-mediated
excision exhibit immediate, complete gonadal sex reversal, as
evidenced by the expression of female-specific markers and the
absence of testis cord formation [8]. Thus, loss of Sox9 expression
is sufficient to explain the failure of male-specific events in XY byg/
byg homozygotes, such as enhanced coelomic region growth,
mesonephric cell migration, and testis cord formation.
We next analysed expression of several other important markers
of male and female gonad development around 11.5 dpc (16 to 19
ts) using immunohistochemical staining of transverse sections. SF-
1 (NR5A-1) is thought to mediate up-regulation of Sox9
transcription in the early XY gonad by acting on a specific
gonadal enhancer (TESCO) in synergy with SRY [55]. We
observed no significant difference in the expression of SF-1
between wild-type and byg/byg XY gonads at this stage, with large
numbers of somatic cells exhibiting nuclear staining in both
genotypic classes (Figure S2A and S2B). FGFR2, a gonadal
receptor for FGF9, has been reported to exhibit a sexually
dimorphic profile of expression in the gonads at 11.5 dpc, with
somatic cells in the body of the XY gonad exhibiting nuclear
localisation of the protein and XX somatic cells, in contrast,
exhibiting a cytoplasmic localisation [12,61]. We also observed
nuclear localisation of FGFR2 in somatic cells of control XY
gonads at 11.5 dpc (Figure S2F and S2G), but in XY byg/byg
gonads, although FGFR2 expression was still prominent, its
localisation was cytoplasmic, resembling XX control gonads at the
same stage (Figure S2H–S2J).
Next, we examined the early expression of FOXL2, a protein
required for normal ovary development [62–65]. Foxl2 transcrip-
tion has been reported to be up-regulated in the developing mouse
gonad around the time of sex determination [66] and restricted to
somatic cells [62,63]. In newborn mice FOXL2 protein is
expressed in the nuclei of pregranulosa cells [63]. We observed
expression of FOXL2 in the nuclei of somatic cells in wild-type
XX gonads at 11.5 dpc (Figure S2E), but negligible expression was
observed in wild-type XY gonads (Figure S2C). However, striking
up-regulation of FOXL2 was observed in the nuclei of somatic
cells of byg/byg XY mutants (Figure S2D). Together with
prominent expression of Wnt4 transcript in mutant gonads at the
same stage (Figure 4F), these data suggest that the ovarian
determining pathway is activated at an early stage in the gonads of
XY byg/byg embryos lacking MAP3K4.
Absence of a number of molecules has been reported to cause
reduction or loss of Sox9 expression in mutant mouse gonads,
including FGF9 [56], FGFR2 [12], WT1 [16,67], and DAX1
[9,29]. Recently, it has been shown that SRY and SF-1
cooperatively bind a specific enhancer element (TESCO) to up-
regulate Sox9 transcription during XY gonad development and
that SOX9 subsequently acts to maintain its own expression by
binding to the same enhancer [55]. Because of this central role for
SRY in regulation of Sox9 expression, we investigated the
expression of Sry in XY byg/byg gonads (Figure 5). Sry transcription
reaches a peak at 11.5 dpc (17–18 ts) in XY mouse gonads, and so
we studied expression at this stage using in situ hybridisation. At
17 ts we observed Sry transcripts in wild-type XY gonads using
WMISH. However, no significant Sry transcription was observed
in XY mutant gonads at the same stage (Figure 5A). At the 19 ts
stage, Sry transcription is reduced in the wild-type gonads and still
absent from mutant (Figure 5B). We utilised quantitative real time-
PCR (qRT-PCR) to confirm this reduction in Sry expression in
mutant gonads at 11.5 dpc (Figure 5C). This qRT-PCR study
revealed an almost 3-fold reduction in Sry transcript levels in XY
byg/byg gonads. Sf1 transcript levels did not differ significantly
between mutant and control gonads, in line with our immuno-
histochemistry data. Fgf9 transcript levels appeared to be reduced
in XY byg/byg gonads, although this difference was not statistically
significant. We then studied the expression of SRY protein in
mutant and control gonads at the same stage using a specific
antibody to SRY [39,68]. Expression of SRY was observed in
somatic cells of the developing gonad at 11.5 dpc in control XY
gonads (Figure 5D and 5F). In contrast, very few SRY-positive
cells were detected in XY byg/byg gonads, which resembled XX
control gonads at the same stage of development (Figure 5E, 5G,
and 5H). High magnification examination of XY byg/byg gonads at
these stages also revealed that those cells that did express SRY did
so at a greatly reduced level (Figure 5I and 5J). In contrast to wild-
type controls, no SRY-positive cells were detected at 11.0 dpc
(Figure 5K and 5L). These studies suggest that appropriate
expression of Sry in XY gonads, at both the transcript and protein
level, is dependent on the presence of MAP3K4. In the absence of
MAP3K4, Sry expression is delayed and, at 11.5 dpc, severely
reduced. Reduced or delayed expression of Sry is known to be a
cause of XY gonadal sex reversal [69,70].
Expression of MAPK Signalling Components in the
Developing XY Gonad
MAP3K4 activity results in activation of the p38 and JNK
MAPK pathways as part of a three-kinase phosphorelay module
[71]. This signalling module is thought to regulate, amongst other
things, the cell’s response to stress including ultraviolet radiation,
heat shock, and osmotic stress [72]. MAP3K4 regulates the
MAPKs p38 and JNK via the phosphorylation of the MAP2Ks
Table 1. Cell proliferation in the XY byg/byg gonad.
Genotype 18 ts 20–22 ts 24 ts
N Mitotic Somatic N Mitotic Somatic N Mitotic Somatic
XY +/+ 6 4.17 268.0 7 7.71 444.0 2 8.50 546.0
XY byg/byg 5 2.00*a 281.4 8 5.50*b 349.3*c 2 3.00 277.0*d
XX +/+ 5 4.20 306.6 6 6.50 340.0*e 4 4.25 317.8*f
Cell counts of somatic cells in mitosis (mitotic) and total somatic cells (somatic) in coelomic region of wild-type (+/+) and byg/byg gonads between 18 and 24 ts stages.
N, independent gonad samples examined.
*, Values are significantly different from respective wild-type values using a two-tailed t-test where p#0.05. Individual p-values: a0.01; b0.043; c0.001; d0.038; e0.002;
f0.003.
doi:10.1371/journal.pbio.1000196.t001
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MKK3/MKK6 and MKK4/MKK7, respectively [42,43]. A
reduction in the number of cells positive for activated MKK4
activity has been reported in the neuroepithelium of embryos
lacking MAP3K4 [44]. Therefore, we assayed for the presence of
activated MKK4 in wild-type XY gonads at 11.5 dpc using
antibodies specific for the phosphorylated form of this protein
(pMKK4). pMKK4-positive cells were observed in the gonad, but
these were primarily found in the coelomic region of the gonadal
periphery (Figure 6A and 6B), a profile reminiscent of pHH3-
positive mitotic cells (Figure 3A). A similar distribution was
observed when pMKK7-positive cells were imaged (Figure 6H).
Given these observations, we assayed directly for co-expression of
pMKK4 and pHH3 in the gonad at 11.5 dpc using immuno-
staining of sections. pMKK4-positive cells were found to be
positive for pHH3 too, both in the gonad and adjacent
mesonephros (Figure 6B–6D). We then assayed for the presence
of activated p38 (pp38) and pMKK7 in the same tissue sections,
and observed a similar pattern of pp38- and pMKK7-positive cells
at the gonadal periphery, which were also positive for pHH3
(Figure 6E–6J). The co-expression of pMKK4 and pHH3 was also
observed in XY byg/byg gonads at the same stage. In the case of
pMKK4, pMKK7, pp38, and pJNK, cells positive for these
activated proteins were still detectable in XY byg/byg gonads at
11.5 dpc (Figure S3), consistent with residual pMKK4 expression
Figure 4. Analysis of Sox9, Wnt4, and Stra8 expression reveals gonadal sex reversal in XY byg/byg embryos. (A) After back-crossing of
the byg mutation to C57BL/6J for at least two generations, XY byg/byg gonads expressed negligible levels of Sox9 (left) in comparison to control XY
gonads (right) at 14.5 dpc. (B) At 13.5 dpc, XY byg/byg gonads express Stra8, a marker of meiotic germs cells usually restricted to the ovary. (C) Wnt4,
a marker of ovarian somatic cells, is expressed in mutant XY gonads (right), in contrast to control gonads (left). (D) On the C3H/HeH background Sox9
transcription is detected at lower levels in the XY byg/byg gonad at 11.5 dpc (right) when compared to wild-type controls (left). Signal in the mutant
gonad appears concentrated towards the centre. (E) After backcrossing to C57BL/6J, Sox9 is expressed abundantly in the XY wild-type gonad at
11.5 dpc (left) but is now absent from XY byg/byg gonads, apart from just a few cells visible in the central region (asterisk, right). (F) XY byg/byg
gonads at 11.5 dpc express the ovarian somatic cell marker Wnt4 (top), in contrast to an XY control gonad (bottom). (G–I) Immunostaining of a
transverse section from a control C57BL/6J XY gonad at 11.5 dpc with anti-PECAM (germ cell, red) and anti-SOX9 (pre-Sertoli cell, green) antibodies
reveals large numbers of somatic cell nuclei (G), in contrast to XY byg/byg (H), and XX wild-type control (I), in which SOX9 protein is not detected at
significant levels.
doi:10.1371/journal.pbio.1000196.g004
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Figure 6. MAPK signalling and XY gonad development. (A–G) Gonadal expression of three activated MAPK signalling components was
examined: phospho-MKK4 (pMKK4), a product of MAP3K4-mediated phosphorylation of MKK4, phospho-p38 (pp38), and phospho-MKK7 (pMKK7). (A)
Anti-pMKK4 antibody detects activated MKK4 (red) in a number of somatic cells in the developing XY gonad at 11.5 dpc (21 ts) after wholemount
immunostaining. Note the concentration of pMKK4-positive somatic cells at the gonadal periphery in the coelomic region. Germ cells are marked by
anti-PECAM antibody (green) and cell nuclei by DAPI. (B–D) Transverse sections of 21 ts XY gonad showing co-expression of pMKK4 and the mitotic
marker pHH3 in cells at the gonadal periphery. The gonad (left) is separated from the mesonephros (right) by a dotted white line. (E–G) Transverse
sections of 21 ts XY gonad revealing co-expression of activated p38 (pp38) and pHH3 in cells at the gonadal periphery. (H–J) Transverse sections
showing similar co-expression of pMKK7 and pHH3. (K–N) The effect of two specific inhibitors of MAPK signalling on XY gonad development in vitro
was studied. (K) Culture of wild-type XY gonads from 11.5 dpc for 48 h in the presence anti-ERK inhibitor U0126 (+, upper three gonads in panel) has
no obvious effect on Sox9 expression in comparison to gonads cultured with vehicle control (v, lower three gonads). Testis cord formation in treated
samples is, however, not as pronounced as in controls. (L, M) Culture of wild-type XY gonads in the presence of p38 inhibitor SB202190 (+, upper rows
of gonads) results in striking, but variable, alterations to Sox9 expression patterns in contrast to vehicle control cultures (v, lower rows), ranging from
loss of transcription in the gonadal poles (asterisks) to complete absence of transcription (gonads beneath brackets). (N) Analysis of XY gonads
cultured in SB202190 also reveals up-regulation of Wnt4 transcription (open arrowheads, upper row) in contrast to vehicle controls, which lack Wnt4
(black arrowheads, lower row). These data suggest that, at least partial, XY gonadal sex reversal is caused by inhibition of p38 from 11.5 dpc. There
were no signs of tissue necrosis or excessive cell death during these experiments. All gonads were from embryos on the C57BL/6J background.
doi:10.1371/journal.pbio.1000196.g006
Figure 5. Loss of Sry transcript and protein expression in XY byg/byg gonads at 11.5 dpc on C57BL/6J. (A) At the 17 ts stage, Sry
transcript is detected throughout an XY control gonad (left) but is absent from the C57BL/6J XY byg/byg gonad (right). (B) By 19 ts, the signal is
diminishing in the XY control gonad (left) and is still not detectable in the XY byg/byg gonad (right). (C) qRT-PCR analysis of Sry, Sf-1, and Fgf9
transcription in XY +/+ and byg/byg gonads at 11.5 dpc (17–18 ts). Error bars for the relative quantitation (RQ) values represent variation across four
biological replicates for each genotype and three technical replicates for each sample. The 2.8-fold reduction in Sry levels in XY byg/byg gonads is
significant (p= 0.02) based on a t-test calculated using average dCT values for the above genes and those of Hprt1. Differences in the levels of Sf-1
(p=0.28) and Fgf9 (p=0.23) were not significant, although there is a trend for reduced expression of Fgf9 in byg/byg. (D) Immunostaining of a
longitudinal section of control XY gonad at 17 ts with anti-SRY (green) and anti-PECAM (red) antibodies reveals abundant expression of SRY in
somatic cell nuclei of the gonad. Tissue beneath the dotted white line in this and subsequent images is mesonephric. (E) In contrast, very few SRY-
positive cells are detectable in a longitudinal section from a XY byg/byg gonad at the same stage. (F) Confocal imaging of a control XY gonad after
wholemount immunostaining with anti-SRY and anti-PECAM antibodies reveals large numbers of SRY-positive somatic cells, in contrast to XY byg/byg
(G) and control XX (H) gonads. (I) High magnification confocal image of wild-type gonad at 11.5 dpc showing large numbers of SRY-positive somatic
cells (green) and germ cells (red). (J) Confocal image of SRY expression in XY byg/byg gonad at 11.5 dpc generated using the same settings as in (I).
Note the greatly reduced number of SRY-positive cells and the reduction in signal intensity in the mutant gonad. (K) A wild-type XY gonad at
11.0 dpc (13 ts) showing SRY-positive cells (green) amongst germ cells (red). (L) In contrast, no SRY-positive cells are detected at 11.0 dpc in an XY
byg/byg gonad.
doi:10.1371/journal.pbio.1000196.g005
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in the neural tube of embryos lacking MAP3K4 [44]. These data
suggest that MAPK signalling is active in the developing XY
gonad at early stages, and is associated with proliferating cells of
the coelomic growth zone, but that alternative pathways exist for
MAPK activation in the gonad in the absence of MAP3K4.
Moreover, given our observation that mitotic somatic cells in the
coelomic region are those cells with activated MKK4/7 and
activated p38, the reduction in the number of proliferative cells in
the XY byg/byg gonad (Figure 3) corresponds to a reduction in the
number of pMKK4/7- and pp38-positive cells. Whilst it is possible
that a gonadal somatic cell activates the MAPK pathway only
once it enters mitosis, it is more consistent with the known role of
MAPK signalling in cell proliferation to conclude that male-
enhanced proliferation in the coelomic region is a MAPK-
dependent process. The reduction of coelomic region growth in
the XY byg/byg gonad at 11.5 dpc is thus explicable by a reduction
in the number of cells exhibiting MAP3K4-mediated phosphor-
ylation of MKK4/7, p38, and possibly other MAPK signalling
components.
Inhibition of p38 MAPK Signalling Disrupts Testis
Development In Vitro
In order to address whether disruption to components of
MAPK signalling can disrupt testis development in vitro, we
cultured wild-type embryonic XY gonads from 11.5 dpc for 48 h
in the presence of highly selective inhibitors of the MAPKs
extracellular signal-related kinase (ERK) (U0126) and p38
(SB202190) [73]. We then assayed for the expression of Sox9
using WMISH (Figure 6K–6M). Similar experiments to address
the role of JNK were not performed because of the unavailability
of highly specific small molecule inhibitors. We observed little
affect on Sox9 expression in gonads treated with ERK inhibitor
when assayed by WMISH, although testis cord formation did not
occur in treated samples with the same efficiency as samples
cultured in vehicle control (Figure 6K). These data are consistent
with other reports that MEK1/ERK inhibitors fail to significantly
disrupt testis development in vitro [74]. In contrast, culturing in
the presence of p38 inhibitor resulted in dramatic reduction of
Sox9 expression, including an almost complete loss of signal in 50%
of treated samples (n=8) (Figure 6L and 6M). Examination of
Wnt4 expression in SB202190-treated cultured explants (n=3) also
revealed robust expression of this ovarian marker in contrast to
vehicle controls (Figure 6N), suggesting that at least partial gonadal
sex reversal was occurring during culture of XY explants because
of abrogation of p38 activity. In this context, it is interesting to
note that human SRY has been recently identified as a possible
target of p38 MAPK signalling in cultured keratinocytes [75].
FGF9-Mediated Activation of Sox9 Transcription Is Not
Abrogated In byg/byg Gonads
Given the importance of two components of the FGF signalling
pathway, FGF9 and FGFR2, in XY gonad development, we next
studied whether byg/byg gonads exhibited defects in this pathway
by determining whether FGF9 was able to activate Sox9
transcription in XY byg/byg gonads. It has previously been
reported that FGF9 is capable of activating Sox9 transcription in
developing XX gonads if they are cultured in the presence of
beads coated in this growth factor [56]. In an attempt to address
the question of which upstream, extracellular signals employ
MAP3K4-dependent phosphorylation during XY gonad develop-
ment, we determined whether FGF9-mediated activation of Sox9
transcription was abrogated in MAP3K4-deficient gonads. XY
gonads from byg/byg and control embryos were cultured at
11.5 dpc for 48 h in the presence of FGF9-coated beads (or beads
coated in bovine serum albumin [BSA]) and were then analysed
for the presence of Sox9 transcripts in cells contacting the bead
using in situ hybridisation. BSA-coated beads did not induce Sox9
transcription in any samples. In contrast, Sox9 transcripts were
clearly detected in the vicinity of beads in both cultured wild-type
XX gonads and in XY byg/byg gonads (Figure 7A and 7B). These
data suggest that MAP3K4 is not an obligatory component of
signal transduction pathways employed by FGF9 to activate
transcription of Sox9 in the developing gonad. However, failure of
normal SRY, and thus SOX9, expression in byg/byg XY gonads
may result in failure to establish the positive feedback loop
between SOX9 and FGF9/FGFR2 [56].
Map3k4 Haploinsufficiency Contributes to Tas
A locus on mouse Chromosome 17 associated with XY sex
reversal and ovotestis formation has previously been described
[40]. This mutation, known as Tas, was identified in a mouse stock
carrying the hairpin-tail (Thp) deletion whilst being crossed to the
C57BL/6J background. The presence of an AKR/J-derived Y
chromosome is also required for the development of ovarian tissue
in XY C57BL/6J Thp/+ individuals. It has been hypothesized that
the Tas mutation resides within the region of the t complex deleted
in Thp and hemizygosity for the relevant locus causes varying
Figure 7. Exogenous FGF9 can activate Sox9 transcription in
gonads lacking functional MAP3K4. (A) Culture of a wild-type XX
gonad (left) from 11.5 dpc for 48 h in the presence of a bead coated in
BSA does not activate Sox9 transcription based on in situ hybridisation
analysis. In contrast, a bead coated in FGF9 does result in up-regulation
of Sox9 in both XX control gonads (centre) and XY byg/byg gonads
(right). The small circle adjacent to each gonad shows the approximate
position of the bead during culture. (B) In a separate experiment, FGF9-
coated beads again activate Sox9 transcription in wild-type XX and XY
byg/byg gonads, but a bead coated in BSA does not activate Sox9
transcription in XY byg/byg gonads. Note the increased size of gonads,
both XX and XY, after exposure to exogenous FGF9. All gonads were
from embryos on the C57BL/6J background.
doi:10.1371/journal.pbio.1000196.g007
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degrees of sex reversal when on the C57BL/6J YAKR background
[41]. This genetic background is known to be very sensitive to
disturbances in the early events of testis development induced by
gene mutation [14], and thus one potential explanation for the Tas
phenotype is haploinsufficiency for a t complex locus that is
ordinarily testis determining. Map3k4 is located on proximal
mouse Chromosome 17 in the region of the t complex and, in the
form of the previously anonymous DNA marker D17Rp17 (still a
synonym of Map3k4, see http://www.informatics.jax.org/search-
es/accession_report.cgi?id =MGI%3A1346875 and GenBank en-
try NM_011948), has been shown to map within the Thp deletion
[76]. Given this map position and the gonadal phenotype of XY
embryos lacking functional Map3k4 on C57BL/6J, we hypothe-
sized that haploinsufficiency for this gene might be, at least
partially, responsible for the Tas gonadal sex reversal phenotype.
We tested this model in two ways. First, we generated embryos
doubly heterozygous for the byg mutation and the Thp deletion. If
Map3k4 resides within the Thp deletion these embryos will lack
Map3k4 function because of failure of complementation and will
recapitulate the phenotype of byg/byg homozygous embryos.
Figure 8 shows that XY byg/+, Thp/+ embryos exhibited
abnormalities of testis development. XY gonads dissected from
doubly heterozygous embryos at 13.5/14.5 dpc showed disruption
to cord morphology or gonadal sex reversal, in which Sox9
transcription is lost (Figure 8A) and Wnt4 transcription is activated
(Figure 8B). Doubly heterozygous mutants also exhibited neural
tube defects (unpublished data). We performed this cross on the
C3H/HeH background because this strain has not previously
been associated with sensitisation to events disrupting testis
development, even given the presence of the YAKR chromosome
[41]. We confirmed, therefore, that Map3k4 resides in the Thp
deletion and that this deletion, combined with a loss-of-function
allele ofMap3k4, causes varying degrees of disruption to XY gonad
development even in the absence of any other predisposing genetic
factors.
Secondly, we performed a cross to test directly whether Map3k4
haploinsufficiency might account for the development of ovarian
tissue in XYAKR Thp/+C57BL/6J individuals. We generated XYAKR
mice after backcrossing of YAKR to C57BL/6J for six generations.
These males were then crossed with females heterozygous for the
targeted null allele of Map3k4 (Map3k4tm1Flv), also on C57BL/6J, to
generate XYAKR Map3k4tm1Flv/+ heterozygotes on a C57BL/6J
background. Nine of these individuals were generated in five litters
and seven were scored as normal males based on examination of the
external genitalia. However, two were scored as phenotypic females
on the basis of external genitalia morphology. Examination of these
sex-reversed individuals revealed the presence of ovaries and uterine
horns. Histological examination of the ovaries from one of these
Figure 8. Hemizygosity for Map3k4 contributes to Tas. (A, B) A genetic complementation test demonstrates that Map3k4 resides in the Thp
deletion of proximal mouse Chromosome 17. XY embryos doubly heterozygous for the Map3k4byg allele and the Thp deletion (XY Thp/+, byg/+), on
the C3H/HeH background, exhibit a range of defects of gonad development similar to byg/byg homozygotes, including testes with regions lacking
clear cord morphology (bracket, A) and XY gonads with an overt ovarian appearance that lack Sox9 transcription (right-hand side gonad, A). Sex-
reversed XY gonads express Wnt4, a marker of ovary development (central gonad, B), in contrast to XY controls. (C) Ovotestis development in
embryos heterozygous for the Map3k4tm1Flv knockout allele, on the C57BL/6J XYAKR background (B6YAKR), characterised by gonadal poles (brackets)
lacking markers of testis development (Sox9), and expressing markers of ovary development (Wnt4).
doi:10.1371/journal.pbio.1000196.g008
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individuals showed them to be smaller than controls and lacking
clearly discernible follicles or ova (unpublished data). Examination of
four other heterozygous males at approximately 11 wk of age
revealed that these had testes of reduced size (ranging from 0.03 g to
0.08 g, mean=0.06 g60.015), in contrast to wild-type controls
(n=6, ranging from 0.08 g to 0.11 g, mean=0.093 g60.009). Small
testes are sometimes an indication of earlier ovotestis development.
To test this possibility, we performed timed matings in order to
examine gonadal morphology in XYAKR Map3k4tm1Flv/+ embryos at
14.5 dpc. Of four XYAKR Map3k4tm1Flv/+ embryos examined, one
contained gonads with an overt ovarian morphology, whilst three
contained ovotestes identified by morphology and the familiar
variegated expression of Sox9 and Wnt4 (Figure 8C). On the basis of
the XY gonadal sex reversal, complete and partial, observed in adult
and embryonic Map3k4tm1Flv/+ individuals on C57BL/6J-XYAKR,
we conclude that haploinsufficiency for Map3k4 is a major
contributory factor to male-to-female sex reversal observed in
XYAKR C57BL/6J Thp/+ individuals.
Discussion
Here we describe evidence demonstrating, for the first time to
our knowledge, an in vivo role for the phylogenetically ancient
MAPK signalling cascade in mammalian sex determination. XY
embryos lacking functional MAP3K4 on a predominantly
C57BL/6J background exhibit embryonic gonadal sex reversal
associated with failure of a number of cellular and molecular
events, paramount amongst these being failure to transcriptionally
up-regulate Sry and, presumably as a consequence, Sox9 in the
developing gonad at 11.5 dpc. Previous studies, often involving
analyses of Mus domesticus-derived Sry alleles on a C57BL/6
background, have suggested that the testis determining pathway is
exquisitely sensitive to levels and timing of Sry: if a threshold level
is not met in a critical time window, ovary development is likely to
ensue [69,70,77]. Thus, attention is naturally focussed on the
possible explanation for reduced Sry expression, at the transcript
and protein levels, in XY byg/byg gonads. Three potential
explanations exist: (i) that a transcriptional regulator (or regulators)
required for transcription of Sry in pre-Sertoli cells does not
function appropriately because of, either directly or indirectly, the
absence of MAP3K4-mediated signalling; (ii) that insufficient
numbers of pre-Sertoli cells are established in the XY byg/byg
gonad; (iii) a combination of both of the above effects. With respect
to the second hypothesis, the coelomic epithelium is thought to be
a source of pre-Sertoli cells in the early XY gonad (prior to
11.5 dpc) [78]. Thus, the reduction in cell proliferation and
gonadal growth in the coelomic region of XY byg/byg mutant
embryos might be considered evidence of a wider range of defects
in the developmental potential of the mutant coelomic epithelium
and associated mesenchyme, perhaps extending to a reduction in
the provision of pre-Sertoli cells, or the provision of pre-Sertoli
cells competent to activate transcription of Sry. This hypothesis is
consistent with the active MAPK signalling that we report in the
coelomic region at 11.5 dpc in XY gonad. However, it should be
noted that in other genetic contexts in which cell proliferation in
the coelomic region of the developing XY gonad is disrupted, such
as in gonads lacking Fgf9 [10,61], Sry transcription is reported to be
unaffected [56]. Thus, there is no established mechanistic link
between prior proliferative defects in the early gonad and
subsequent loss of Sry expression. However, given the reported
role of FGF9 in promoting gonadal cell proliferation [61], it is
possible that loss of MAP3K4 results in an inability of coelomic
region cells to efficiently transduce FGF9 signal produced by initial
SRY-positive pre-Sertoli cells. This, in turn, would result in failure
to establish a positive feedback mechanism by which cell
proliferation and SRY expression mutually promote each other,
causing insufficient provision of pre-Sertoli cells. This model would
explain the reduced numbers of SRY-positive cells detected in XY
byg/byg gonads between 11.0 and 11.5 dpc (Figure 5). In order to
establish whether there is a paucity of cells migrating into the XY
byg/byg gonad at around 11.2–11.4 dpc to populate the pre-Sertoli
cell niche, it will be necessary to perform single-cell labelling
experiments similar to those used to establish the role of the
coelomic epithelium in this process [78]. However, establishing
whether a marked cell was undergoing, or had undergone, active
MAPK signalling of the appropriate sort would be technically
daunting.
With respect to the first hypothesis, little is known about the
transcriptional control of Sry, although several potential activators
have been described including M33, WT1(+KTS), GATA4/
FOG2, and SF1 [79]. This hypothesis is supported by the presence
of a few SRY-positive cells in the XY byg/byg gonad at 11.5 dpc
that exhibit a significant reduction in the intensity of the SRY
signal, and also the existence of FOXL2-positive cells in the XY
byg/byg gonad at 11.5 dpc, since this lineage is arguably the
ovarian equivalent of the pre-Sertoli cell lineage of the testis.
Evidence already exists for MAPK-dependent phosphorylation of
SF1 [80,81] and GATA4 [82] in other contexts, as a means of
increasing their transcriptional activation potency. It is also
noteworthy that SRY, which is phosphorylated in humans [83],
has recently itself been proposed to be a target of p38-mediated
signalling pathways on the basis of cell line studies in vitro [75].
We are currently attempting to identify reduced phosphorylation
of candidate testis-determining proteins in MAP3K4-deficient
embryonic gonads. However, we cannot rule out the possibility
that previously uncharacterised molecules are the key effectors of
MAPK-mediated events during gonadogenesis. Moreover,
MAP3K4-mediated events required for normal Sry transcription
may occur in the progenitors of pre-Sertoli cells, in the form of
programming, rather than pre-Sertoli cells themselves. In
conclusion, the data suggest that the third hypothesis may best
explain the observations concerning SRY expression.
The similarity in the phenotypes of mice lacking the Map3k4
gene [44] and those merely lacking a functional kinase domain of
the same gene [45], strongly argues that MAP3K4 functions
primarily to regulate MAPK signalling through its kinase domain.
Thus, although we cannot formally exclude additional functions,
we conclude that loss of functional MAP3K4 in the byg mutant
results in disrupted MAPK signalling during gonad development.
Although ours is the first report of a requirement for MAPK
signalling in sex determination in vivo, one previous report has
implicated a MAPK scaffolding protein, Vinexin-c, in regulation
of Sox9 transcription during gonad development [84]. However,
the fetal gonads of both XX and XY embryos lacking Vinexin-c
are morphologically normal and adult mice of the same genotypes
are viable and fertile. Moreover, Sox9 transcript levels in Vinexin-c
2/2 XY gonads at 12.5 dpc are 75% that of Vinexin-c 2/+
gonads, suggesting that any modulation of Sox9 transcription by
Vinexin-c is relatively modest. These data appear to be consistent
with reported organ culture studies in which the MAPK inhibitor
PD98059 did not significantly inhibit testis cord formation in XY
gonad explants [74]. In contrast to the Vinexin-c studies, we
observe an almost complete absence of Sox9 at the sex determining
stage of gonad development (11.5 dpc) in C57BL/6J XY embryos
lacking MAP3K4 and a complete failure of testis cord formation at
later stages.
One possible explanation of the apparent discrepancy in these
observations with respect to the role of MAPK signalling in testis
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development is the focus in other studies on the MEK-ERK
pathway of MAPK signalling, sometimes called the classical
MAPK cascade [73]. It has been proposed that Vinexin-c
mediates its effects on Sox9 transcription in vitro via male-specific
activation of the MAPK, ERK [84], and PD98059 is a specific
MEK-ERK inhibitor [73,85]. The focus on MEK-ERK in other
studies is likely a consequence of the inviting similarities between
requirements for Sox9 up-regulation during gonad development
and chondrogenesis. FGF-mediated activation of Sox9 transcrip-
tion during chondrogenesis has been shown to be blocked by the
MAPK inhibitor U0126 [86]. U0126 is also a specific MEK-ERK
inhibitor [73,85]. Given that MAP3K4 is thought to act ultimately
by activation of the MAPKs p38 and JNK [42,43], the focus on
ERK activation and the consequences of its disruption as a means
of determining the role of MAPK signalling during gonad
development may have been overly restrictive and resulted in
misleading conclusions. Our studies utilising specific small
molecule inhibitors of MAPK signalling in organ culture assays
corroborate previous observations that MEK-ERK inhibition does
not significantly disrupt Sox9 expression in vitro. However, in
contrast, they do suggest a possible role for p38 in gonadal Sox9
transcriptional regulation and testis cord formation. The signifi-
cance of these in vitro observations for the possible role of p38 in
the aberrant phenotype of the MAP3K4-deficient gonad is
unclear, given that Sry transcription is already at its peak at
11.5 dpc, the approximate stage at which gonadal explants were
employed for in vitro culture experiments. Inhibition of p38 at
these stages may disrupt testis-determining events downstream of
regulation of Sry transcription, perhaps related to regulation of
Sox9 expression, in a manner analogous to that reported for the IL-
1b-dependent induction of SOX9 expression in human articular
chondrocytes [87], or disruption of SOX9 function itself. Mice
constitutively lacking the alpha isoform of p38 die at around
10.5 dpc, before gonadogenesis can be fully examined [88]. For
this reason, it is important to remain open-minded about how
many distinct steps in testis development require MAPK-
dependent events. Teasing these out genetically will require a
conditional null allele of Map3k4 (and genes encoding other
MAPK signalling elements) and inducible, cell-type-specific Cre
lines. It will also be important to determine whether disruption to
individual MAP2Ks and MAPKs also results in abnormal gonad
development in vivo, or whether loss of MAP3K function is
disruptive to a broader range of MAPK signalling events,
including potential compensatory ones, and thus more likely to
result in phenotypic abnormalities.
In addition to downstream events mediated by MAP3K4, it is
not yet clear which upstream signals employ MAP3K4 for their
transduction. Analogies with chondrogenesis, as described above,
have tended to focus attention on the role of FGF signalling and its
use of MAPK for its transduction. Moreover, FGF9 is known to be
required for the male-specific elevated proliferation rate in the
gonadal coelomic region at around 11.5 dpc [61]. However, we
have demonstrated that the ability of exogenous FGF9 to activate
Sox9 transcription during gonad culture remains unaltered in the
absence of MAP3K4. These data do not definitively demonstrate
that FGF9 does not employ MAP3K4-mediated signal transduc-
tion during regulation of Sox9 expression during male gonad
development in vivo, but they do suggest that such a pathway is
not obligatory. Moreover, initial up-regulation of Sox9 transcrip-
tion, along with Sry transcription, proceeds as normal in
embryonic gonads lacking FGF9 [56]. It is, rather, the
maintenance phase of Sox9 transcription in developing male
gonads that is disrupted in the absence of FGF9. Taken together,
these observations suggest that we should look at other pathways,
in addition to FGF, for the activating signals that require
MAP3K4 for their transduction. Although activation of MAPK
is a widespread phenomenon, ligand binding to receptor tyrosine
kinases (RTK) is commonly associated with activation of this
intracellular signalling cascade [89]. Interestingly, the insulin
receptor tyrosine kinase gene family (Ir, Igf1r, and Irr) has
previously been shown to be required for testis determination
through its regulation of Sry expression [17], and a number of
reports describe a requirement for MAPK in signal transduction
through this family of receptors in different biological contexts
[90,91]. Similarly, loss of another RTK, PDGFRa, also disrupts
testis development [21] and PDGF signalling is reported to employ
MAPK [92]. Finally, in addition to RTK activity, prostaglandin
D2 (PGD2) has been shown to influence Sertoli cell differentiation
and SOX9 activity [39,57,58], presumably through its G-protein
coupled receptors, DP and CRTH2 [93], although this is not
established. PGD2 signalling in other contexts has been shown to
require MAPK [94,95]. Although the details of MAPK activation
in these disparate systems vary, they are all potentially relevant to
the phenotype of MAP3K4-deficient gonads because evidence
suggests cross-talk between distinct MAPK pathways [75].
Despite the above observations, we cannot rule out the
possibility of a role for a hitherto unrecognised growth factor or
other extracellular signal in the employment of MAP3K4 during
testis development. One virtue of invoking a requirement for
MAP3K4 in FGF9-mediated signalling during gonadogenesis in
vivo is that this model does not predict a requirement for sexually
dimorphic expression of MAP3K4, consistent with Map3k4
expression data. We observed near ubiquitous expression of
Map3k4, including male and female gonads, although higher levels
were detected in particular cell types. Because of a lack of the
relevant antibodies, we were unable to assay for the presence of
activated MAP3K4 specifically in XY gonads, although such
activation is predicted by the existence of MAP4Ks [96]. It should
also be noted that the same explanatory virtue applies to invoking
a requirement for MAP3K4 in activation of Sry transcription.
We also report here data indicating that haploinsufficiency for
Map3k4 is sufficient to account for Tas [40], a phenomenon that
has remained unexplained at the molecular level since its discovery
more than 20 y ago. XY embryos heterozygous for the
Map3k4tm1Flv mutation on the C57BL/6J-YAKR background
exhibit testicular abnormalities, including XY ovary and ovotestis
development, reminiscent of XYAKR C57BL/6J Thp/+ embryos
[40]. Moreover, two adult XY Map3k4tm1Flv/+ individuals
developed as phenotypic females, and both contained ovaries.
Four others exhibited testicular hypoplasia, which is associated
with prior ovotestis development. It is unclear, however, despite
the role for Map3k4 haploinsufficiency established here, whether
additional testis-determining genes exist in the region deleted in
Thp, or whether chromosome deletions themselves predispose XY
embryos to sex reversal by inhibitory effects on fetal
growth [97].
Significantly, it has been demonstrated that, on the appropriate
genetic background, the loss of a single copy of a male-determining
gene can result in XY gonadal sex reversal [14]. It has been
proposed that such phenotypic effects in mice caused by a single
disrupted allele mimic the more common situation in humans,
where loss of a single functional copy of genes such as SF1, SOX9,
orWT1 can result in the development of XY females [98,99]. Our
findings suggest that the loss of a single copy of Map3k4, caused by
the Thp deletion or targeted gene deletion, is another example of
such a case. Thus, we propose that haploinsufficiency of MAP3K4
could be the cause of previously unassigned cases of XY gonadal
dysgenesis in humans [100]. A second, independent case of Tas on
MAP3K4 Is Required for Mouse Sex Determination
PLoS Biology | www.plosbiology.org 14 September 2009 | Volume 7 | Issue 9 | e1000196
the C57BL/6J XYAKR background (B6-TAS) is caused by the T-
Orleans deletion (TOrl), which overlaps with the hairpin tail
deletion and also includes Map3k4/D17Rp17 [41]. Interestingly, it
has been proposed that B6-TAS in TOrl/+ XYAKR mice is due to
biologically insufficient levels of Sry expression [101]. An
analogous explanation of the mechanism underlying the Thp/+
XYAKR phenotype is consistent with the report here of delayed
and reduced levels of Sry transcription in byg/byg XY gonads at
11.5 dpc. Levels of Sry transcription in XY embryonic gonads of
Map3k4byg/+ or Map3k4tm1Flv/+ heterozygotes on the C57BL/6J-
YAKR background have yet to be determined, but this experiment
will form part of a more extensive analysis of gonadogenesis in
these individuals.
Our data have opened a novel entry point into the molecular
genetic control of mammalian sex determination and, in particular,
the regulation of Sry expression. We know of no other higher
organisms in which MAPK signalling is thought to regulate sexual
development, although pheromone response during mating in yeast
and other fungi is known to require a highly related pathway of
kinase activity [102–104]. We are currently investigating the role of
other proteins required for MAPK signalling in mouse gonad
development, utilising in vivo and in vitro methods. The ultimate
aim of these studies is to clarify the pathway of MAPK signalling
that operates during gonadogenesis and determine precisely how it
interacts with the molecular events constituting sex determination.
Finally, our study suggests that forward genetic screens in the mouse
should be considered as another important tool for identifying
vertebrate sex determining genes.
Materials and Methods
Forward Genetic Screen, Mouse Breeding, and Embryo
Generation
We have previously described the mutagenesis and screening
methodology employed here [105]. Briefly, a three-generation
(G3) recessive mutagenesis screen was used in which C57BL/6J
males were injected with ENU and outcrossed to C3H/HeH
females; F1 (founder) males were used to establish pedigrees by
mating to C3H/HeH and F2 female offspring were backcrossed to
their father. Using this breeding scheme it is expected that
approximately one in eight embryos in a pedigree will be
homozygous for any given ENU-induced mutation. G3 embryos
were examined at 13.5 and 14.5 dpc for developmental abnor-
malities. Examination of pedigree RECB/31 (byg) revealed several
embryos with abnormal male gonad development. Affected
embryos were used for genetic mapping with a 55-marker genome
wide SNP panel (sequences available on request). byg was
maintained by backcrossing to C3H/HeH and, following
identification of the Map3k4 mutation, genotyped for the mutant
SNP by pyrosequencing. Timed matings were used to generate
embryos at specific stages. Breeding pairs were set up at
approximately 3 pm and vaginal plugs were checked the following
morning. Noon on the day of the plug was counted as 0.5 dpc.
Embryos were typed for chromosomal sex as previously described
[106].
Genotyping for the byg mutation was performed using a PCR-
based pyrosequencing assay using the following primers: Forward
PCR primer: 59-AGGACTATGAACGGTACGC-39; Reverse
PCR primer: 59-Bio-CGCAGCTTCTGATTTAGATC-39; Se-
quencing primer 59-GCCAAGGACTTTGAGG-39. byg was
backcrossed to C3H/HeH and C57BL/6J. Analysis of byg/byg
embryos on C57BL/6J was performed between generations n=2
to n=5.
The generation and maintenance of mice lacking Map3k4 has
been previously described [44,107]. Map3k4-deficient mice utilised
here were maintained on a C57BL/6J background. Hairpin tail
(Thp) mice, originally archived on a mixed genetic background,
were rederived using independent in vitro fertilisation (IVF) with
both C57BL6/J and C3H/HeH oocytes. Thp was maintained on
both C57BL/6J and C3H/HeH. XY sex reversal was observed on
the former, but not the latter, genetic background. Thp carriers
were identified by the shortened tail [108]. Confirmation of the
presence of the AKR-derived Y chromosome was performed by
using a PCR assay based on that described in [109], which exploits
a Zfy-2 polymorphism between M. domesticus and M. musculus.
Expression Studies
WMISH to explanted gonads was performed as previously
described [31,106]. The following probes were used for WMISH:
Sox9 [110]; Oct4 [111]; 3b-HSD [112]; Wnt4 (IMAGE clone
40044945), Sry [113], Stra8 (IMAGE clone 40045823), Map3k4
(IMAGE clone 5705378).
qRT-PCR
Total RNA and protein were extracted from individual 11.5 dpc
(17–18 ts) mouse urogenital ridges (comprising gonad and mesoneph-
ros) using the Nucleospin RNA/protein isolation kit (MACHEREY-
NAGEL) following manufacturer’s instructions. The quantity and
quality of the RNA was assessed using the Nanodrop ND1000 (Isogen
Life Science) and by gel electrophoresis. A two-step real-time analysis
approach was taken. First, cDNA was synthesised using the AB High
Capacity cDNA Reverse Transcription Kit using 1 mg of total RNA.
The following TaqMan assays (Applied Biosystems [AB])
were used: Sf1 (Mm00496060_m1); Fgf9 (Mm00442795_m1); Sry
(Mm00441712_s1); Hprt1 (Mm01545399_m1). For each assay,
reactions were performed in triplicate using AB Fast Mastermix in a
final volume of 20 ml (5 mg of cDNA added). Real-time amplification
was performed on an AB 7500 Fast machine, using the manufacturer’s
recommended program for Fast Mastermix. Analysis of the results was
performed using AB software, employing a ddCt method with the gene
Hprt1 as the endogenous control. For each assay four biological
replicates and three technical replicates were performed. Statistical
analysis was performed using a non-paired t-test on the average dCt
values calculated for the three technical replicates of each independent
sample (biological replicate).
Immunohistochemistry and Confocal Imaging
The following antibodies were used in this study: SRY [39];
SOX9 [39]; FGFR2 (Santa Cruz number sc-122); SF1, a kind gift
from K. Morohashi; FOXL2: antibodies were raised in rabbits
against the peptides MMASYPEPEDAAGAALL and
WDHDSKTGALHSRLDL, previously utilised in [114]. Anti-
bodies were affinity purified and tested prior to use: platelet/
endothelial cell adhesion molecule (PECAM) (BD Bioscience
number 553708); phospho-histone H3 (pHH3, Sigma number
HH908 or Upstate number 06-570); phospho-MKK4 (Cell
Signalling number 9151); phospho-MKK7 (Cell Signalling
number 4171); phospho-p38 (Cell Signalling number 4631);
phospho-JNK/SAPK (Cell Signalling number 9251); cleaved
caspase-3 (Cell Signalling number 9661S); MAP3K4 (Sigma
m7194). Wholemount immunohistochemistry was performed as
previously described [106]. Section immunohistochemistry was
performed on the basis of protocols described in [39]. Whole-
mount samples were imaged using a Leica TCS SP5 confocal
microscope. Sections were visualised using a Zeiss Axiophot 2.
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Gonadal Cell Proliferation
After immunostaining with anti-PECAM and anti–pHH3
(Upstate, number 06-570) and nuclear counterstaining with
aqueous DAPI, the central third of each gonad was imaged using
a Leica TCS SP5 confocal microscope (406). A Z-stack series
(10 mm steps) was generated for each sample and then three
central sections were chosen for cell counts in the coelomic region
(pHH3-positive cells and DAPI-stained nuclei). Sections were
separated by 20 mm to ensure that no cell was counted twice.
Differences between samples were assessed using a two-tailed t-
test.
Organ Culture
Culturing of embryonic gonads and recombination experiments
between subdissected gonads and marked mesonephroi were
performed based on methodologies described in [50] and [106].
Briefly, XY urogenital ridges (UGRs), consisting of gonad and
attached mesonephros, were collected at 11.5 dpc (16–19 ts stage)
and cultured to establish conditions under which testis cords
formed reliably after 48 h culture. Samples were incubated on
1.5% agar blocks at 37uC/5% CO2 in Dulbecco’s Minimal Eagle’s
Medium (DMEM)/10% fetal calf serum (FCS)/50 mg/ml ampi-
cillin/200 mM L-glutamine in the presence of MAPK inhibitors
or vehicle control. For recombination cultures, 11.5 dpc XY male
UGRs from byg/byg mutant embryos were subdissected into
component gonad and mesonephros in PBS. The gonads were
recombined with mesonephroi from XY Tg(GFPU)5Nagy/J
embryos (ubiquitously expressing GFP) and cultured for 48 h, as
above. Migration from the marked mesonephros into the attached
gonad was imaged using a Leica TCS SP5 confocal microscope.
No migration was observed into control XX gonads during these
experiments.
The following MAPK signalling inhibitors were used: SB202190
(p38 inhibitor, Sigma) and U0126 (ERK [Mek1] inhibitor, Sigma).
SB202190 was used at a final concentration of 25 mM in culture
medium, in line with previously reported in vitro studies
employing this inhibitor [115–117]. U0126 was also used at a
final concentration of 25 mM [86,118,119].
To examine the effects of exogenous FGF9 expression in XX
gonad development we employed the methodology described in
[56]. Briefly, agarose beads (Sigma-Aldrich) were incubated in
culture medium containing 50 ng/ml FGF9 protein (R&D
Systems), or 0.1% BSA, in a humidified chamber at room
temperature for at least 5 h. Beads were then placed adjacent to
gonads (n=3 for each genotypic class) and cultured for
approximately 42 h.
Ethics Statement
Animal procedures employed in this study were authorized by
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Supporting Information
Figure S1 Gonadal sex reversal and failure of meso-
nephric cell migration into XY byg/byg embryonic
gonads during organ culture. (A) In vitro culture of wild-
type XY embryonic gonads at 11.5 dpc for 48 h results in testis
cord formation visualised by in situ hybridisation with the Sertoli
cell marker, Sox9. The asterisk indicates Sox9 expression in the
metanephric kidney, which was still attached to this explant when
dissected prior to culture. (B) Culture of XY byg/byg gonads results
in no testis cord formation and very low levels of Sox9
transcription, which is limited to the gonadal region adjacent to
the mesonephros, as in wild-type female gonads. (C) Wild-type
explants do not express Wnt4 in the developing gonad after
culture, but do express this marker in the mesonephros. (D) XY
byg/byg explants exhibit high levels of Wnt4 expression in the
gonad, similar to XX gonads at 13.5 dpc, indicating gonadal sex
reversal in cultured XY mutant gonads. (E) Culture of a wild-type
XY gonad adjacent to a stage-matched mesonephros derived from
a line expressing GFP (recombination) reveals migration of
endothelial cells into the gonad to form cord-like structures and
an aggregation of cells in the coelomic region. (F) Culture of an
XY byg/byg gonad with a marked mesonephros reveals negligible
cell migration into the gonad (indicated by the region within the
white dotted line).
Found at: doi:10.1371/journal.pbio.1000196.s001 (2.28 MB TIF)
Figure S2 Analysis of SF1, FOXL2, and FGFR2 protein
expression in XY control and byg/byg gonads at
11.5 dpc. (A, B) Transverse section showing SF1 expression
(green) in a large number of somatic cells of control XY gonads (A)
and XY byg/byg gonads (B). SF1 signal is nuclear in contrast to the
cytoplasmic staining of germ cells with PECAM (red). (C–E)
FOXL2 is not detected in control XY gonads at this stage (C) but
nuclear signal (green) is detected in somatic cells of XY byg/byg (D)
and control XX gonads (E). (F–J) FGFR2 (green) is expressed in
somatic cell nuclei of control XY gonads (F, G). White arrowhead
indicates individual nucleus on section counterstained with DAPI
(blue). FGFR2 is still detected in XY byg/byg gonads (H, I), but
signal is restricted to the cytoplasm of somatic cells (arrowhead, I).
This cytoplasmic localisation is reminiscent of FGFR2 expression
in control XX gonads of the same stage (J). All gonads were from
embryos on the C57BL/6J background.
Found at: doi:10.1371/journal.pbio.1000196.s002 (2.60 MB TIF)
Figure S3 Immunohistochemical analysis of pMMK4,
pMKK7, pp38, and pJNK on transverse sections of wild-
type and byg/byg XY gonads at 11.5 dpc. In each case, the
activated MAPK signalling molecule is detected in somatic cells
(red), whilst germ cells and endothelial cells are detected by
PECAM staining (green). Counterstaining is with DAPI (blue).
The gonad is to the left of the dotted line in each image and the
mesonephros is to the right.
Found at: doi:10.1371/journal.pbio.1000196.s003 (2.91 MB TIF)
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